Sunitinib Impurity 58, with the CAS number 856436-17-4, is a chemical compound associated with the pharmaceutical agent sunitinib, which is primarily used in cancer treatment, particularly for renal cell carcinoma and gastrointestinal stromal tumors. As an impurity, it is typically a byproduct of the synthesis of sunitinib and may possess distinct chemical properties that can influence the overall efficacy and safety profile of the drug. While specific characteristics such as molecular weight, solubility, and spectral data are not detailed here, impurities like this one are often characterized by their structural similarity to the parent compound, potentially affecting pharmacokinetics and pharmacodynamics. Regulatory agencies require thorough characterization and quantification of impurities to ensure drug quality and patient safety. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the properties of impurities is crucial for maintaining the integrity of drug products and ensuring compliance with safety standards.

Sunitinib Impurity 58

856436-17-4: Sunitinib Impurity 58, with the CAS number 856436-17-4, is a chemical compound associated with the pharmaceutical agent sunitinib, which is primarily used in cancer treatment, particularly for renal cell carcinoma and gastrointestinal stromal tumors. As an impurity, it is typically a byproduct of the synthesis of sunitinib and may possess distinct chemical properties that can influence the overall efficacy and safety profile of the drug. While specific characteristics such as molecular weight, solubility, and spectral data are not detailed here, impurities like this one are often characterized by their structural similarity to the parent compound, potentially affecting pharmacokinetics and pharmacodynamics. Regulatory agencies require thorough characterization and quantification of impurities to ensure drug quality and patient safety. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the properties of impurities is crucial for maintaining the integrity of drug products and ensuring compliance with safety standards.

3-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)-5-fluoroindolin-2-one

CAS 856436-17-4

Sunitinib Impurity 58

3-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)-5-fluoroindolin-2-one

Ref: 54-PC1006428